Mar. 10 at 5:45 PM
The B2i Digital team is pleased to announce that Bora Pharmaceuticals (OTCQX:
$BORAY | TWSE: 6472) is participating in the Life Sciences Virtual Investor Forum, co-hosted by Virtual Investor Conferences and Zacks Small Cap Research, on Thursday, March 12, 2026, at 9:30 AM EDT.
The Life Sciences Virtual Investor Forum is a B2i Digital Featured Conference. For more details, please visit: https://b2idigital.com/otc-life-sciences-virtual-investor-forum
Virtual Investor Conferences brings together public companies and a global audience of retail and institutional investors for live executive presentations, Q&A sessions, and on-demand replays. The platform is open to public companies listed on NYSE, Nasdaq, TSX, CSE, ASX, and the OTC Markets.
Founded in 2007, Bora Pharmaceuticals is a leading pharmaceutical services company operating under a “Dual Engine” model that integrates contract development and manufacturing (CDMO) capabilities with commercial expertise. The company partners with pharmaceutical and biotech companies to optimize product development, accelerate launches, and scale supply to meet global patient needs. Bora is also expanding its R&D and sales infrastructure with a focus on niche and rare disease markets. Through strategic acquisitions in Taiwan, Canada, and the U.S., the company has established itself as a global leader in both small- and large-molecule CDMO services.
Presenting on behalf of Bora Pharmaceuticals will be Bobby Sheng, Chairman and Chief Executive Officer, who founded the company in 2007 and has led it to become Taiwan’s top CDMO by manufacturing capacity, with products exported to more than 100 countries. He has been recognized as CEO of the Year at the CPHI Awards and holds a bachelor’s degree in economics from the University of California, Berkeley.
To register for this presentation, visit: https://www.virtualinvestorconferences.com/wcc/eh/4814904/lp/5255333/bora-pharmaceuticals-otcqx-boray-twse-6472?utm_source=b2i&utm_medium=marketing&utm_campaign=0326LifeSciencesVIC
For more information about Bora Pharmaceuticals, visit: https://bora-corp.com/investors/
Content about any specific company was provided and approved by that company or is available in the public domain. B2i Digital, Inc. has not independently verified the accuracy of the information contained herein. The content contained herein is informational only, and no content contained herein shall be considered an offer to solicit the sale of any security or make a recommendation to purchase a security. B2i Digital is not a broker-dealer or investment adviser.
